nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Elder Pharmaceuticals Limited (NSE India Code : ELDERPHARM) SELL

Company Name :

Enter Company Name or NSE Code

ELDERPHARM Technical Levels

Resistance 2		306.88
Resistance 1		302.77
PIVOT		299.93
Support 1		295.82
Support 2		288.87

ELDERPHARM Fundamentals

Earning Growth		38.78%
Profit Margin		9.04
PE		7.26
EPS		40.75
Quarter		30-Sep-11

ELDERPHARM Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

ELDERPHARM Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

ELDERPHARM Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

ELDERPHARM Share Price on 5-10-2012

Open		297.55
High		299
Low		295.1
Close		298.1
Volume		2641
Change		-0.2 (-0.07%)

Series		EQ
Date of Listing		19-Apr-00
Paid Up Value		10
Face Value		10
Market Capital		291.685 Crores
52 Week High/Low		408 / 266.1

Sponsored Advertisement

Elder Pharmaceuticals Limited Company Profile

Elder Pharmaceuticals (EPL) was set up in 1987. The company is mainly into manufacture of bulk drugs and formulations. Elder has manufacturing facilities in Nerul, Pawane and Patalganga (all in the state of Maharashtra). Formulations and bulk drugs contribute almost 75% to the company`s revenues. In the year 1991, the company achieved R&D recognition from the Government of India.The mission of the company is to occupy a prominent place in national and international health care arena with focus on research and global collaborations. The group has three companies namely Elder Pharmaceutical, Elder HealthCare (EHC) and Elder Projects. The main therapeutic areas of interest for the company are osteoporosis and wound-care. The company has also positioned itself in the emerging markets of cardiology, respiratory disorders and cerebral diseases. Other areas of activity are dermatology, nutritional products and antioxidants. Bulk drugs manufactured like ampicillin trihydrate, amoxycillin trihydrate and cloxacillin sodium (oral) are mainly used for captive consumption in its own healthcare set up, surplus if any being sold in the domestic market or exported. EPL entered into alliances with foreign companies for manufacture and sale of their products under license from them. Besides, EPL has also introduced some of its own brands like Shelcal, Eldervit-12 INJ, Chymoral Forte, Amifru and I-VIT. It also has a presence in the OTC segment and sells the Tiger range of products from Singapore, SOLO Eucamenth tablets, AMPM mouthwash and toothbrushes. The company has tie up with Haw Par, Fugisawa and Paul Hartmann. The exports of company commenced in 1991 when it received its first order from Russia for Colloidal Bismuth Subcitrate (Denol) tablets. The company received the ``Certificate of Merit`` from the ministry of commerce, government of India for outstanding export performance during the period 1992-93. It enjoys an export house status since 1994 with shipment being made to African and South Asian countries. The company has diversified into sale of medical equipment. Export markets include Switzerland, Germany, England, Denmark and a few African countries.

ELDERPHARM Intraday Realtime Chart

ELDERPHARM Corporate Announcements

DATE	PURPOSE
02-Aug-12	Outcome of Board Meeting
14-Jun-12	Disclosure under SEBI Takeover Regulations
15-May-12	Financial Result Updates
08-May-12	News Clarification
04-May-12	Disclosure under SEBI Takeover Regulations

ELDERPHARM Corporate Actions

DATE	PURPOSE
17-Sep-12	AGM/DIV-RS.3/- PER SHARE
15-Sep-11	Dividend-Rs.3/- Per Share
15-Sep-11	DIVIDEND-RS.3/- PER SHARE

ELDERPHARM Board Meetings

MEETING DATE	PURPOSE
09-Aug-12	Results/Dividend
02-Aug-12	Miscelleneous
15-May-12	Un-audited Financial Results
10-Feb-12	Un-audited Financial Results
04-Nov-11	Un-audited Financial Results

ELDERPHARM Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is the maximum brokerage that a broker/sub broker can charge?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer